Safety and Efficacy of Treatment With Autologous Mesenchymal Stem Cells in Patients With Radiation-Induced Xerostomia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Safety of Treatment with Autologous Mesenchymal Stem Cells in Patients with Radiation-Induced Xerostomia: Primary Results of the MESRIX Phase 1/2 Randomized Trial
Clin. Cancer Res 2022 Apr 29;[EPub Ahead of Print], CD Lynggaard, C Grønhøj, SB Jensen, R Christensen, L Specht, E Andersen, TT Andersen, UM Ciochon, GS Rathje, AE Hansen, H Stampe, A Fischer-Nielsen, C von BuchwaldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.